Non-cirrhotic
Showing 1 - 25 of >10,000
Pathological Spectrum of Porto-sinusoidal Vascular Disease in
Recruiting
- Portal Hypertension
- +6 more
-
Sector-12, Chandigarh, IndiaDr. Madhumita Premkumar
Sep 19, 2023
Intrahepatic Non Cirrhotic Portal Hypertension Trial in Clichy (Apixaban, Placebo)
Recruiting
- Intrahepatic Non Cirrhotic Portal Hypertension
- Apixaban
- Placebo
-
Clichy, FranceBeaujon hospital
Mar 21, 2022
Portal Hypertension, Non-Cirrhotic Portal Hypertension, Non-Cirrhotic Portal Fibrosis Trial in Rio de Janeiro (Hepatic vein
Not yet recruiting
- Portal Hypertension
- +9 more
- Hepatic vein pressure gradient measurement
- +2 more
-
Rio de Janeiro, RJ, BrazilHospital Universitário Clementino Fraga Filho / Universidade Fed
Jan 30, 2023
Gastric Cancer, Complication,Postoperative, Complications; Gastrointestinal, Postoperative Trial in Istanbul (MELD-Na score)
Completed
- Gastric Cancer
- +3 more
- MELD-Na score
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Aug 5, 2022
Non-cirrhotic, Chronic Hepatitis B Trial in New Delhi (Tenofovir alafenamide fumarate)
Recruiting
- Non-cirrhotic, Chronic Hepatitis B
- Tenofovir alafenamide fumarate
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Feb 23, 2022
Recurrence of Thrombosis or Thrombotic Extension, in Event of
Completed
- Portal Vein Thrombosis
- Local Cause
-
Caen, Calvados, FranceChu de Caen
Apr 29, 2022
Non-Alcoholic Steatohepatitis (NASH) Trial in Fort Myers, Sarasota (Pemvidutide, Placebo)
Recruiting
- Non-Alcoholic Steatohepatitis (NASH)
- Pemvidutide
- Placebo
-
Fort Myers, Florida
- +1 more
Aug 10, 2023
Non-Alcoholic Steatohepatitis Trial in China (HEC96719, Placebo)
Recruiting
- Non-Alcoholic Steatohepatitis
- HEC96719
- Placebo
-
Beijing, Beijing, China
- +8 more
May 25, 2022
PADUA PREDICTION SCORE in Cirrhotic Patients
Recruiting
- Portal Thrombosis
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Mar 16, 2023
Liver Cirrhosis, Portal Hypertension, Non-Cirrhotic Portal Hypertension Trial in Freiburg (Implantation of a transjugular
Recruiting
- Liver Cirrhosis
- +5 more
- Implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
-
Freiburg, GermanyUniversity Medical Center Freiburg, Department of Medicine II
Mar 22, 2023
Portal Hypertension in Patients With CVID (CVID-pHT)
Recruiting
- Non-Cirrhotic Portal Hypertension
- Common Variable Immunodeficiency
- Ultrasound including color doppler ultrasound
-
Freiburg, GermanyUniversity Medical Center Freiburg, Department of Medicine II
Nov 21, 2023
NASH - Nonalcoholic Steatohepatitis Trial in United States (TERN-201, Placebo)
Active, not recruiting
- NASH - Nonalcoholic Steatohepatitis
- TERN-201
- Placebo
-
Tucson, Arizona
- +10 more
Jun 1, 2022
Natural History of Noncirrhotic Portal Hypertension
Recruiting
- Cystic Fibrosis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)
Recruiting
- Hepatitis B, Chronic
- IMC-I109V-101 Single Ascending Dose
- IMC-I109V-101 Multiple Ascending Doses
-
Los Angeles, California
- +19 more
May 10, 2023
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis Trial in Worldwide (AZD4831, Placebo)
Recruiting
- Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
- AZD4831
- Placebo
-
Chandler, Arizona
- +45 more
Jan 11, 2023
NASH - Nonalcoholic Steatohepatitis Trial in United States (TERN-101, Placebo)
Completed
- NASH - Nonalcoholic Steatohepatitis
- TERN-101
- Placebo
-
Chandler, Arizona
- +30 more
Jul 12, 2022
Cystic Fibrosis Liver Disease, Portal Hypertension Due to Cystic Fibrosis (Disorder), Portal Hypertension, Noncirrhotic Trial
Completed
- Cystic Fibrosis Liver Disease
- +2 more
- TIPS
- (no location specified)
Aug 30, 2021
Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
- +5 more
-
Beijing, Beijing, ChinaPeking University Peoples Hospital
Feb 16, 2021
Cirrhosis, Muscle Cramp, Ascites Trial in Ann Arbor (Household Remedy, Tap water)
Completed
- Cirrhosis
- +2 more
- Household Remedy
- Tap water
-
Ann Arbor, MichiganUniversity of Michigan
Dec 2, 2021
Non-alcoholic Fatty Liver Disease Trial (GSK4532990, Placebo)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease
- GSK4532990
- Placebo
- (no location specified)
Dec 14, 2022
Hepatitis C Trial in Alor Star (Sofosbuvir 400 MG, Ravidasvir 200mg)
Recruiting
- Hepatitis C
- Sofosbuvir 400 MG
- Ravidasvir 200mg
-
Alor Star, Kedah, MalaysiaHospital Sultanah Bahiyah
May 17, 2021